GNRH1 and ovarian hyperstimulation syndrome: All participants underwent a GNRH antagonist protocol, which included OS with recombinant FSH and hMG, and a recombinant hCG or GNRH agonist (leuprolide acetate) trigger for final oocyte maturation if there was concern regarding ovarian hyperstimulation syndrome.